Chronic Antiprogestin Therapy Produces a Stable Atrophic Endometrium With Decreased Fibroblast Growth Factor: A 1-Year Primate Study on Contraception and Amenorrhea
article
OA: closed
CC0
⤵ 11 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- Alterations in Endometrial Stromal Cell Tissue Factor Protein and Messenger Ribonucleic Acid Expression in Patients Experiencing Abnormal Uterine Bleeding While Using Norplant-2 Contraception<sup>1</sup> via openalex
- Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study. via openalex
- Antiprogestins: Mechanism of Action and Contraceptive via openalex
- Dating the Endometrial Biopsy via openalex
- Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis via openalex
- doi:10.1210/jcem.78.2.8106633 via openalex
- doi:10.1210/jc.76.2.513 via openalex
- doi:10.1016/0010-7824(93)90142-t via openalex
- W6662394256 via openalex
- doi:10.1016/0010-7824(93)90024-2 via openalex
- doi:10.1016/s0021-9258(17)32664-9 via openalex
- doi:10.1210/endo-129-5-2385 via openalex
- doi:10.1016/0010-7824(89)90004-8 via openalex
- doi:10.1093/humupd/1.2.162 via openalex
- doi:10.1093/oxfordjournals.humrep.a138767 via openalex
- doi:10.1016/s0002-9378(11)91627-5 via openalex
- doi:10.1111/j.1749-6632.1997.tb48523.x via openalex
- doi:10.1016/s0015-0282(16)53174-4 via openalex
- doi:10.1210/edrv-8-2-95 via openalex
- doi:10.1016/0010-7824(90)90094-c via openalex
- doi:10.1093/oxfordjournals.humrep.a138268 via openalex
- doi:10.1002/jcp.1041370329 via openalex
- doi:10.1210/jcem.76.2.8432797 via openalex
- doi:10.1056/nejm199210083271501 via openalex
- doi:10.1210/jcem-71-4-1074 via openalex
Cited by (11)
- The endometrial response to modulation of ligand-progesterone receptor pathways is reversible 2021
- Moduladores selectivos del receptor de la progesterona 2016
- Progesterone Receptor Modulators Induce Apoptosis in Mammary Tumors and Uterine Leiomyomas 2012
- Effects of Antiprogestins on the Uterus 2008
- Progesterone receptor antagonists and selective progesterone receptor modulators: proven and potential clinical applications 2007
- Inhibition of Proliferation of Endometrial Stromal Cells by Trichostatin A, RU486, CDB-2914, N-Acetylcysteine, and ICI 182780 2006
- Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications 2005
- Progesterone antagonists and progesterone receptor modulators: an overview 2003
- 10.1016/s0246-1064(15)67502-8 2000
- Progesterone receptor modulators and progesterone antagonists in women's health 2000
- The role of selective oestrogen receptor modulators in the treatment of endometrial bleeding in women using long-acting progestin contraception 2000
Source provenance
- openalex
- last seen: 2026-05-11T06:18:49.075943+00:00
License: CC0
· commercial use OK